DT BioPharma Consulting
The Gold Standard in Bio-Pharma Strategy.
At DT BioPharma Consulting, we work to transform complex data into powerful narratives.
We provide tailored publication services designed to meet your most ambitious communication and training objectives.
With a foundation of deep industry expertise, we deliver the insights and precision needed to achieve both your immediate milestones and your long-term strategic vision.
About Us
Global Expertise. Ethical Innovation.
We assist global pharma, academia, and biotech organizations in navigating the evolving landscape of medical affairs and evidence generation.
Our Core Capabilities:
Strategic Publication Planning: Seamless management grounded in GPP and ICMJE standards.
Omnichannel Communication: Integrated congress planning and digital engagement.
Patient Advocacy: Making scientific evidence accessible, relevant, and actionable for those who need it most.
Future-Ready Solutions: Guiding teams through the ethical integration of AI and digital tools.
Our Mission: To increase scientific credibility and advance communication that empowers both the medical community and the patients it serves.
Services
Global Expertise. Ethical Innovation.
We assist global pharma, academia, and biotech organizations in navigating the evolving landscape of medical affairs and evidence generation.
Our Core Capabilities:
Strategic Publication Planning: Seamless management grounded in GPP and ICMJE standards.
Omnichannel Communication: Integrated congress planning and digital engagement.
Patient Advocacy: Making scientific evidence accessible, relevant, and actionable for those who need it most.
Future-Ready Solutions: Guiding teams through the ethical integration of AI and digital tools.
Our Mission: To increase scientific credibility and advance communication that empowers both the medical community and the patients it serves.
Selected Publications
Bharadia, Geissler, Robson, Lastikova, Porter, Richmond, Johnson, Roch, Toroser (2025) Seven actions toward advancing patient authorship and collaboration in peer-reviewed publications. Patient. 18(5): 403-414
Puthige, Toroser, Mehra, Mukundan, Kapadia, (2025) GPP 2022: perspectives, sentiments, and feedback from the publications community. Curr Med Res Opin, 41(5): 879-885
deTora, Toroser, Sykes, Vanderlinden, Plunkett, Lane, Hanekamp, Dormer, DiBiasi, Bridges, Baltzer, Citrome (2022) Good Publication Practice (GPP) Guidelines for company-sponsored biomedical research: 2022 Update.Ann Intern Med. 175(9): 1298-1304
Toroser, Carlson, Robinson, Gegner, Girard, Smette, Nilsen, O’Kelly. (2017) Factors impacting time to acceptance and publication for peer-reviewed publications. Curr Med Res Opin, 33(7): 1183-1189
Toroser, Robinson, Gegner, Smith, Nilsen, Hyatt, Johnson, Hassan, Gatchalian (2016) Systematic review of reports describing potential impact of the Sunshine Act on peer-reviewed medical publications. Curr Med Res Opin, 32(3):547-53
Toroser, deTora, Cairns, Juneja, Georgieva, Weigel, Pepitone (2015) The Sunshine Act and medical publications: Guidance from professional medical associations. Postgrad Med. 127(7) 752-7
Toroser, Yarian, Orr, Sohal (2006) Gamma-glutamylcysteine ligase regulation. Biochim Biophys Acta, 1760(2): 233-44
Toroser, Huber (1998) 3-hydroxy-3-methylglutarylCoA reductase kinase regulation. Arch Biochem Biophys 355(2): 291-300
Useful Links
GPP 2022: deTora, Toroser, Sykes et al.,…Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update :GPP GUIDELINES
ICMJE: International Committee of Medical Journal Editors (Recommendations): www.icmje.org
MPIP: Medical Publishing Insights & Practices:www.mpip-initiative.org
Reporting Guidelines
Professional Organizations
International Society for Medical Publication Professionals (ISMPP): Link: ISMPP
Asian Council of Science Editors (ACSE): Link: ACSE
Q1 Productions: Link: Q1 Conferences
STARTUP BOSTON: Link: Events
CONSORT: Consolidated Standards of Reporting Trials. Link: CONSORT
PRISMA: Preferred Reporting Items for Systematic Reviews and MetaAnalyses. Link:PRISMA
CHEERS: Consolidated Health Economic Evaluation Reporting Standards. Link:CHEERS
STROBE: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)Statement: guidelines for reporting observational studies. Link:STROBE
SPIRIT: Reporting of surrogate endpoints in randomised controlled trial protocols (SPIRIT-Surrogate): extension checklist with explanation and elaboration. Link: SPIRIT
SQUIRE: SQUIRE 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. Link:SQUIRE